Serum Occludin as a Biomarker to Predict the Severity of Acute Ischemic Stroke, Hemorrhagic Transformation, and Patient Prognosis

Li Weili, Qi Zhifeng, Kang Huining, Qin Xuzhen, Song Haiqing, Sui Xueqin, Ren Yi, Ji Xunming, Ma Qingfeng, Jian Liu Ke

Table 2 Subgroup analysis of Serum occludin levels in CI patients.

Subgroup n Serum occludin (ng/ml) P values Age (yr) All 171 0.029a 0-45 13 3.49±1.00 46-65 74 4.24±1.29 66-79 55 4.14±1.43 >80 29 4.90±1.51 Sex All 171 0.639 Male 124 4.23±1.34 Female 47 4.35±1.53 Diabetes All 171 0.013 Non-Diabetes 118 4.03±1.24 Diabetes 53 4.59±1.28 Hypertension All 171 0.66 Non-hypertension 61 4.21±1.53 Hypertension 110 4.31±1.31